Stay updated on RGX-111 Gene Therapy in MPS I Clinical Trial
Sign up to get notified when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.

Latest updates to the RGX-111 Gene Therapy in MPS I Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.5 was added, replacing the previous v3.5.4. This indicates a minor page revision for the study record.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a newer version of the page content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page’s footer revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than any change to the study record.SummaryDifference0.1%

- Check54 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded glossary terms: Mucopolysaccharidosis, MPS-I-H/S and Mucopolysaccharidosis type 1, expanding disease terminology related to the study.SummaryDifference0.1%

- Check76 days agoChange Detected- Hurler-Scheie Syndrome was removed from the list of conditions on the study page. This updates the documented scope of conditions associated with the study.SummaryDifference0.1%

Stay in the know with updates to RGX-111 Gene Therapy in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.